Company Filing History:

11 out of 56

Cyclacel Limited

Shanghai Genomics, Inc.

patents

Years Active: 2002-2012

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8309550 - Kinase inhibitors and their use as pharmaceutical agents (2012-11-13),

2. 7902361 - Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy (2011-03-08),

3. 7897605 - Pyrimidine compounds (2011-03-01),

4. 7576091 - Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases (2009-08-18),

5. 7432260 - Pyrimidine compounds (2008-10-07),

6. 7427627 - N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds (2008-09-23),

7. 7388015 - N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds (2008-06-17),

8. 7262202 - Inhibitors of cyclin dependent kinases as anti-cancer agent (2007-08-28),

9. 7153931 - Transport vectors (2006-12-26),

10. 6992169 - Carrier based drug delivery system (2006-01-31),

11. 6699854 - Anti-cancer compounds (2004-03-02),

12. 6531479 - Anti-cancer compounds (2003-03-11),

13. 6472507 - Carrier based drug delivery system (2002-10-29),

Title: Shudong Wang: Innovator in Pharmaceutical Chemistry

Introduction

Shudong Wang is a prominent inventor based in Angus, GB, known for his significant contributions to pharmaceutical chemistry. With a total of 13 patents to his name, he has made remarkable advancements in the field of kinase inhibitors and therapeutic compounds.

Latest Patents

Among his latest patents, Wang has developed innovative compounds that act as inhibitors of one or more protein kinases. These compounds are described in detail in his patent titled "Kinase inhibitors and their use as pharmaceutical agents." This patent outlines pharmaceutical compositions and medicaments that incorporate these inhibitors, along with methods for their application in treating conditions mediated by protein kinases. Another notable patent is focused on "Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy." This invention relates to compounds that can be used in the treatment of various disorders, including proliferative and viral disorders, as well as conditions like stroke, alopecia, and diabetes.

Career Highlights

Shudong Wang has worked with Cyclacel Limited, a company recognized for its innovative approaches in drug development. His work has significantly impacted the pharmaceutical industry, particularly in the development of targeted therapies.

Collaborations

Wang has collaborated with notable professionals in the field, including Peter Martin Fischer and Gavin Wood. These collaborations have further enhanced his research and development efforts.

Conclusion

Shudong Wang's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a leading inventor in the industry. His work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.